MONT-SAINT-HILAIRE, QUEBEC--(MARKET WIRE)--Sep 14, 2007 -- Axcan Pharma Inc. ("Axcan" or the "Company") (Toronto:AXP.TO - News)(NasdaqGS:AXCA - News) today announced that on Tuesday, September 18, 2007, President and Chief Executive Officer, Frank Verwiel, M.D., will present an overview of the Company at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference to be held in London, U.K. This presentation will take place at 3.20 p.m. local time (10.20 a.m. Eastern time).
